Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News EC approves ADCETRIS for treating CD30+ Stage IV Hodgkin lymphoma The European Commission (EC) has officially expanded the approval of Takeda Pharmaceutical’s ADCETRIS (brentuximab vedotin) to include the… bypharmanewsdailyFebruary 11, 2019